It has not yet received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
Persistent fatigue despite adequate sleep is often a sign of cellular decline rather than lifestyle habits alone
French Peptides is not a pharmacy, compounding facility, or medical supplier, nor is it a compounding pharmacy or chemical compounding facility as defined under Section XNUMXA of the Federal Food, Drug, and Cosmetic Act, or an outsourcing facility as defined under Section XNUMXB
J Physiol Pharmacol 46: 3744
Neuroprotective Properties In addition to sleep research, DSIP has been investigated in models of neuroprotection and adaptation to environmental stressors
Research suggests it may promote blood vessel formation and enhance healing processes, though human clinical data remain limited